Clinical trial / 2019
Intragastric quinine decreased ghrelin, motilin, prospective food consumption, and hedonic food intake in healthy women.
In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).
- Study type
- Randomized controlled trial
- Who was studied
- 15 healthy women
- What was measured
- Brain responses, appetite-related sensations, plasma gastrointestinal hormones, and hedonic food intake
THE PAPER
Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms.
Iven J, Biesiekierski JR, Zhao D, Deloose E, O'Daly OG, Depoortere I, Tack J, Van Oudenhove L. Nutr Neurosci, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.